Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

Debora Spar Biography and Net Worth

Director of Thermo Fisher Scientific

Spar is the Harvard MBA Class of 1952 professor of business administration. She bacame Barnard College's seventh president in 2008. She previously spent 17 years on the faculty of Harvard Business School, where from 1991 she held a variety of positions, including Spangler Family Professor of Business Administration, director of the division of research and faculty development, and chair of the business, government, and international economy unit. She is a member of the Academy of Arts and Sciences and serves on the board of Value Retail LLC

What is Debora L. Spar's net worth?: The estimated net worth of Debora L. Spar is at least $632,528.35 as of February 12th, 2024. Ms. Spar owns 1,207 shares of Thermo Fisher Scientific stock worth more than $632,528 as of December 21st. This net worth approximation does not reflect any other assets that Ms. Spar may own. Learn More about Debora L. Spar's net worth.
How do I contact Debora L. Spar?: The corporate mailing address for Ms. Spar and other Thermo Fisher Scientific executives is 168 Third Avenue, Waltham MA, 02451. Thermo Fisher Scientific can also be reached via phone at (781) 622-1000 and via email at [email protected]. Learn More on Debora L. Spar's contact information.
Has Debora L. Spar been buying or selling shares of Thermo Fisher Scientific?: Debora L. Spar has not been actively trading shares of Thermo Fisher Scientific over the course of the past ninety days. Most recently, Debora L. Spar sold 164 shares of the business's stock in a transaction on Monday, February 12th. The shares were sold at an average price of $546.97, for a transaction totalling $89,703.08. Following the completion of the sale, the director now directly owns 1,207 shares of the company's stock, valued at $660,192.79. Learn More on Debora L. Spar's trading history.
Who are Thermo Fisher Scientific's active insiders?: Thermo Fisher Scientific's insider roster includes Michael Boxer (SVP), Lisa Britt (Senior Vice President and Chief Human Resources Officer), Marc Casper (Chairman, President & CEO), Joseph Holmes (VP & CAO), Peter Hornstra (CAO), Syed Jafry (VP), Michel Lagarde (EVP), Jim Manzi (Director), Gianluca Pettiti (EVP), Debora Spar (Director), Mark Stevenson (COO), and Stephen Williamson (CFO). Learn More on Thermo Fisher Scientific's active insiders.
Are insiders buying or selling shares of Thermo Fisher Scientific?: During the last twelve months, insiders at the medical research company sold shares 22 times. They sold a total of 142,511 shares worth more than $81,094,921.00. The most recent insider tranaction occured on December, 2nd when CEO Marc N Casper sold 10,000 shares worth more than $5,302,600.00. Insiders at Thermo Fisher Scientific own 0.3% of the company. Learn More about insider trades at Thermo Fisher Scientific.
Information on this page was last updated on 12/2/2024.

Debora L. Spar Insider Trading History at Thermo Fisher Scientific

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/12/2024	Sell	164	$546.97	$89,703.08	1,207
12/15/2022	Sell	200	$561.39	$112,278.00	979
5/2/2022	Sell	200	$544.36	$108,872.00	810

Debora L. Spar Buying and Selling Activity at Thermo Fisher Scientific

Thermo Fisher Scientific Company Overview

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $524.05

$515.00

$526.43

50 Day Range

MA: $543.04

$501.50

$603.79

2 Week Range

Now: $524.05

$493.30

$627.88

Volume

2,713,540 shs

Average Volume

1,556,857 shs

Market Capitalization

$200.45 billion

P/E Ratio

32.86

Dividend Yield

0.29%

Beta

0.77